Grand Pharma's stock price surged 5.01% during intraday trading on Monday, reflecting strong positive momentum.
The sharp rise appears to be driven by news that the company's Board Chairman, Tang Weikun, recently purchased 60,000 shares at HK$6.5 each. This transaction, which increased his total holding to 1.06 million shares, is seen by the market as a significant vote of confidence in the company's future prospects from its top leadership.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments